Literature DB >> 27066416

Submandibular Duct Re-routing for Drooling in Neurologically Impaired Children.

Prem Sagar1, K K Handa2, Sheffali Gulati3, Rajeev Kumar1.   

Abstract

Drooling is a challenging situation to manage especially in neurologically impaired pediatric population. Numerous surgical procedures have been described in literature but none of them is standardized. We evaluate the effectiveness of bilateral submandibular duct rerouting and sublingual gland excision in drooling paediatric patients. Prospective interventional study was conducted from November 2007 to September 2009 in twenty-eight pediatric patients with drooling who had failed conservative treatment modalities. Patients underwent bilateral submandibular duct transposition and sublingual gland excision. Patients were assessed pre-operatively, at 7, 30 and 90 days after surgery for drooling severity, frequency as per Thomas-Stonell and Greenberg classification and also number of bibs changed per day. Result was categorized using Wilkie and Brody criteria for assessing effectiveness of the surgery. Twenty-eight patients were successfully operated. All patients were followed-up for a duration of at least 3 months. The success rate achieved in term of control of drooling was 95.2 % at 3 months follow up. Statistically significant difference (p < 0.001) was noted in pre-operative and postoperative mean values for severity and frequency of drooling and also bibs/day. Transient, minor complications (n = 5/28, 17.8 %) were encountered following this surgical procedure. Bilateral submandibular duct rerouting and sublingual gland excision in drooling paediatric patients is a simple and effective surgery with minor operative morbidity. Concomitant sublingual gland excision bilaterally helps in reducing the incidence of ranula formation significantly.

Entities:  

Keywords:  Cerebral palsy; Drooling; Ranula; Submandibular duct re-routing; Submandibular duct transposition

Year:  2015        PMID: 27066416      PMCID: PMC4809808          DOI: 10.1007/s12070-015-0926-4

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  18 in total

1.  The surgical management of drooling--a 15 year follow-up.

Authors:  T P O'Dwyer; B J Conlon
Journal:  Clin Otolaryngol Allied Sci       Date:  1997-06

2.  Submandibular duct relocation for drooling: a 10-year experience with 194 patients.

Authors:  W S Crysdale; A White
Journal:  Otolaryngol Head Neck Surg       Date:  1989-07       Impact factor: 3.497

3.  Three treatment approaches and clinical factors in the reduction of drooling.

Authors:  N Thomas-Stonell; J Greenberg
Journal:  Dysphagia       Date:  1988       Impact factor: 3.438

Review 4.  Drooling and its management in cerebral palsy.

Authors:  S R Harris; A H Purdy
Journal:  Dev Med Child Neurol       Date:  1987-12       Impact factor: 5.449

5.  Does the addition of sublingual gland excision to submandibular duct relocation give better overall results in drooling control?

Authors:  F Glynn; T P O'Dwyer
Journal:  Clin Otolaryngol       Date:  2007-04       Impact factor: 2.597

6.  Management of drooling by transposition of the submandibular ducts and excision of the sublingual glands.

Authors:  N McAloney; C J Kerawala; L F A Stassen
Journal:  J Ir Dent Assoc       Date:  2005

7.  The effect of submandibular duct rerouting in the treatment of sialorrhea in children.

Authors:  R T Cotton; M A Richardson
Journal:  Otolaryngol Head Neck Surg       Date:  1981 Jul-Aug       Impact factor: 3.497

8.  Persistent drooling: treatment by bilateral submandibular duct transposition and simultaneous sublingual gland excision.

Authors:  M Ethunandan; D W Macpherson
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

9.  Surgical management of drooling.

Authors:  R L Guerin
Journal:  Arch Otolaryngol       Date:  1979-09

10.  Surgical management of drooling in the neurologically damaged child.

Authors:  T P O'Dwyer; C Timon; M A Walsh
Journal:  J Laryngol Otol       Date:  1989-08       Impact factor: 1.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.